186 related articles for article (PubMed ID: 32779609)
1. Glucocorticoid-Induced Bacterial Endocarditis in COVID-19 Pneumonia - Something to Be Concerned About?
Regazzoni V; Loffi M; Garini A; Danzi GB
Circ J; 2020 Sep; 84(10):1887. PubMed ID: 32779609
[No Abstract] [Full Text] [Related]
2. Reactivation of COVID-19 pneumonia: A report of two cases.
Ravioli S; Ochsner H; Lindner G
J Infect; 2020 Aug; 81(2):e72-e73. PubMed ID: 32389787
[No Abstract] [Full Text] [Related]
3. "Reversed halo sign" on 3D CT in COVID-19.
Bekci T
Diagn Interv Radiol; 2020 Jul; 26(4):379. PubMed ID: 32352916
[No Abstract] [Full Text] [Related]
4. Update on use of chloroquine/hydroxychloroquine to treat coronavirus disease 2019 (COVID-19).
Gao J; Hu S
Biosci Trends; 2020 May; 14(2):156-158. PubMed ID: 32281583
[TBL] [Abstract][Full Text] [Related]
5. Chloroquine and Hydroxychloroquine in COVID-19: Challenges and the Need for Caution in Low-Resource Settings.
Islam M
J Coll Physicians Surg Pak; 2020 Jun; 30(6):78. PubMed ID: 32723461
[No Abstract] [Full Text] [Related]
6. The Saga of Hydroxychloroquine and COVID-19: A Cautionary Tale.
Schluger NW
Ann Intern Med; 2020 Oct; 173(8):662-663. PubMed ID: 32673059
[TBL] [Abstract][Full Text] [Related]
7. QT Interval Control to Prevent Torsades de Pointes during Use of Hydroxychloroquine and/or Azithromycin in Patients with COVID-19.
Wu TC; Sacilotto L; Darrieux FCDC; Pisani CF; Melo SL; Hachul DT; Scanavacca M
Arq Bras Cardiol; 2020 Jun; 114(6):1061-1066. PubMed ID: 32638906
[No Abstract] [Full Text] [Related]
8. Does hydroxychloroquine combat COVID-19? A timeline of evidence.
Alia E; Grant-Kels JM
J Am Acad Dermatol; 2020 Jul; 83(1):e33-e34. PubMed ID: 32283236
[No Abstract] [Full Text] [Related]
9. A Word of Caution in the Use of Hydroxychloroquine in the Elderly COVID-19 Population.
Martinez Navarro W; Ly L; Segal MS; Shukla AM
Asia Pac J Ophthalmol (Phila); 2020; 9(4):374-375. PubMed ID: 32740071
[No Abstract] [Full Text] [Related]
10. Imatinib for COVID-19: A case report.
Morales-Ortega A; Bernal-Bello D; Llarena-Barroso C; Frutos-Pérez B; Duarte-Millán MÁ; García de Viedma-García V; Farfán-Sedano AI; Canalejo-Castrillero E; Ruiz-Giardín JM; Ruiz-Ruiz J; San Martín-López JV
Clin Immunol; 2020 Sep; 218():108518. PubMed ID: 32599278
[No Abstract] [Full Text] [Related]
11. BET 2: Hydroxychloroquine in the treatment of COVID-19.
Howard L; Baombe J; Reynard C
Emerg Med J; 2020 Jul; 37(7):451-453. PubMed ID: 32616659
[No Abstract] [Full Text] [Related]
12. Targeting the inflammatory cascade with anakinra in moderate to severe COVID-19 pneumonia: case series.
Aouba A; Baldolli A; Geffray L; Verdon R; Bergot E; Martin-Silva N; Justet A
Ann Rheum Dis; 2020 Oct; 79(10):1381-1382. PubMed ID: 32376597
[No Abstract] [Full Text] [Related]
13. Asthma and COVID-19: Is asthma a risk factor for severe outcomes?
Johnston SL
Allergy; 2020 Jul; 75(7):1543-1545. PubMed ID: 32358994
[No Abstract] [Full Text] [Related]
14. Ventricular arrhythmia risk due to chloroquine / hydroxychloroquine treatment for COVID-19: Should it be given.
Malviya A
Indian Heart J; 2020; 72(2):131-132. PubMed ID: 32534688
[No Abstract] [Full Text] [Related]
15. Hydroxychloroquine and Azithromycin to Treat Patients With COVID-19: Both Friends and Foes?
Mégarbane B; Scherrmann JM
J Clin Pharmacol; 2020 Jul; 60(7):808-814. PubMed ID: 32434282
[No Abstract] [Full Text] [Related]
16. Hydroxychloroquine in the management of critically ill patients with COVID-19: the need for an evidence base.
Taccone FS; Gorham J; Vincent JL
Lancet Respir Med; 2020 Jun; 8(6):539-541. PubMed ID: 32304640
[No Abstract] [Full Text] [Related]
17. Novel approach for low-dose pulmonary delivery of hydroxychloroquine in COVID-19.
Fassihi SC; Nabar NR; Fassihi R
Br J Pharmacol; 2020 Nov; 177(21):4997-4998. PubMed ID: 32562278
[No Abstract] [Full Text] [Related]
18. Hydroxychloroquine pharmacokinetic in COVID-19 critically ill patients: an observational cohort study.
Painvin B; Guillot P; Verdier MC; Gacouin A; Maamar A
Intensive Care Med; 2020 Sep; 46(9):1772-1773. PubMed ID: 32514594
[No Abstract] [Full Text] [Related]
19. Fungal Infections in COVID-19-Positive Patients: A Lack of Optimal Treatment Options.
Silva LN; de Mello TP; de Souza Ramos L; Branquinha MH; Roudbary M; Dos Santos ALS
Curr Top Med Chem; 2020; 20(22):1951-1957. PubMed ID: 33040728
[No Abstract] [Full Text] [Related]
20. [Not Available].
Nau JY
Rev Med Suisse; 2020 Apr; 16(690):756-757. PubMed ID: 32301315
[No Abstract] [Full Text] [Related]
[Next] [New Search]
